IRIS
GIANNONI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.867
EU - Europa 9.532
AS - Asia 8.793
SA - Sud America 2.433
AF - Africa 204
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 24
Totale 37.881
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.976
SG - Singapore 3.866
RU - Federazione Russa 3.140
CN - Cina 2.066
BR - Brasile 1.997
GB - Regno Unito 1.670
IT - Italia 1.618
VN - Vietnam 1.146
DE - Germania 790
CA - Canada 689
HK - Hong Kong 609
UA - Ucraina 604
SE - Svezia 307
DK - Danimarca 270
IE - Irlanda 178
FI - Finlandia 177
FR - Francia 176
AR - Argentina 173
IL - Israele 167
NL - Olanda 158
IN - India 157
PL - Polonia 155
MX - Messico 145
BD - Bangladesh 130
TR - Turchia 120
ID - Indonesia 109
EC - Ecuador 99
ES - Italia 87
JP - Giappone 86
ZA - Sudafrica 78
PK - Pakistan 73
IQ - Iraq 67
AT - Austria 66
LT - Lituania 36
MA - Marocco 36
UZ - Uzbekistan 35
CO - Colombia 34
AE - Emirati Arabi Uniti 31
VE - Venezuela 28
EU - Europa 27
PY - Paraguay 27
CL - Cile 25
PE - Perù 19
UY - Uruguay 18
KE - Kenya 17
TN - Tunisia 17
EG - Egitto 15
RO - Romania 15
SA - Arabia Saudita 15
BE - Belgio 14
AU - Australia 10
AZ - Azerbaigian 10
CH - Svizzera 10
HN - Honduras 10
NP - Nepal 10
DZ - Algeria 9
NZ - Nuova Zelanda 9
TH - Thailandia 9
DO - Repubblica Dominicana 8
JO - Giordania 8
CZ - Repubblica Ceca 7
KG - Kirghizistan 7
KR - Corea 7
PH - Filippine 7
TW - Taiwan 7
BG - Bulgaria 6
BO - Bolivia 6
IR - Iran 6
KZ - Kazakistan 6
NI - Nicaragua 6
CR - Costa Rica 5
GE - Georgia 5
GY - Guiana 5
JM - Giamaica 5
MG - Madagascar 5
MT - Malta 5
PA - Panama 5
PS - Palestinian Territory 5
QA - Qatar 5
TT - Trinidad e Tobago 5
AO - Angola 4
CI - Costa d'Avorio 4
DM - Dominica 4
ET - Etiopia 4
GR - Grecia 4
HU - Ungheria 4
OM - Oman 4
RS - Serbia 4
AL - Albania 3
AM - Armenia 3
GD - Grenada 3
LU - Lussemburgo 3
LV - Lettonia 3
LY - Libia 3
NO - Norvegia 3
PT - Portogallo 3
SI - Slovenia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
Totale 37.831
Salva come PNG Salva come JPEG
Città #
Dallas 3.694
Singapore 2.007
Beijing 1.032
Ashburn 1.027
Southend 907
Chandler 733
Fairfield 584
Houston 534
Los Angeles 516
Hong Kong 499
Woodbridge 469
San Mateo 436
Moscow 434
Ann Arbor 422
Chicago 413
Falls Church 406
Seattle 361
Ho Chi Minh City 333
Cambridge 331
Jacksonville 323
Wilmington 315
The Dalles 263
New York 256
Ottawa 255
Boardman 218
Hefei 215
Dearborn 214
São Paulo 206
Hanoi 186
Buffalo 185
Dublin 176
Salt Lake City 173
Pisa 172
Portsmouth 170
Stevenage 164
Beauharnois 163
Tel Aviv 152
Munich 149
Dong Ket 147
Warsaw 142
Santa Clara 141
Lawrence 132
Milan 129
Rome 129
London 117
Brooklyn 107
Montreal 94
Stockholm 83
Tampa 81
Denver 79
Tokyo 77
Orem 76
Poplar 75
Atlanta 72
Montréal 72
Chennai 70
Elk Grove Village 68
Istanbul 66
Frankfurt am Main 63
Johannesburg 62
Rio de Janeiro 61
San Diego 61
Nuremberg 59
Mexico City 58
Florence 57
Phoenix 56
Fremont 53
Helsinki 53
Toronto 50
Boston 47
Amsterdam 45
Turku 44
Council Bluffs 42
San Francisco 41
Manchester 40
Brasília 39
Guayaquil 39
Redwood City 39
Ankara 37
Dongguan 36
Belo Horizonte 35
Haiphong 35
Tashkent 35
Lappeenranta 34
Da Nang 33
Lancaster 33
Biên Hòa 32
Curitiba 32
Sterling 32
Genoa 31
Querétaro 31
Ariccia 30
Campinas 29
Porto Alegre 29
San Jose 29
Quito 28
Vienna 28
Bologna 27
Guangzhou 27
Old Bridge 27
Totale 22.749
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.591
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 444
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 439
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 350
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 309
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 307
A simple echocardiographic score to rule out cardiac amyloidosis 301
Central sleep apnea and cardiovascular disease state-of-the-art 299
Treating chemoreflex in heart failure: modulation or demolition? 290
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 290
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 288
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 285
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 279
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 278
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 275
Adrenergic activation in heart failure: blockade or rebalance? 271
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 266
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 265
Prediction of the chemoreflex gain by common clinical variables in heart failure 257
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 257
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 257
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 256
A simple echocardiographic score to rule out cardiac amyloidosis 253
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 250
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 249
[Central apneas and cardiovascular diseases] 248
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 248
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 242
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 240
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 237
How to take arms against central apneas in heart failure 232
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 228
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 228
B-type natriuretic peptide secretion following scuba diving 227
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 223
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 223
An atypical case of cardiac amyloidosis. 219
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 216
Screening the health status of people working in a university 215
Improved survival in limited scleroderma-related pulmonary artery hypertension 215
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 215
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 212
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 211
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 210
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 209
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 207
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 207
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 206
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 205
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 204
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 204
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 204
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 203
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 202
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 202
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 202
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 201
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 201
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 201
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 199
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 199
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 198
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 198
Prognostic value of plasma Renin activity in heart failure. 197
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 197
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 196
High-risk NSTEMI due to subclavian artery atherothrombosis in a prior coronary artery bypass graft patient 196
Automatic analysis of EEG pattern during sleep in Cheyne-Stokesrespiration in heart failure. 194
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 190
Pathophysiology of Central Apneas in Heart Failure 190
Reversal of ticagrelor-induced arrhythmias and cheyne-stokes respiration with aminophylline infusion 190
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 190
Breath-hold task induces temporal heterogeneity in electroencephalographic regional field power in healthy subjects 188
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 187
Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. 187
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. 187
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 187
Modern diagnostic and therapeutical approach to cardiac AL amyloidosis and neuroendocrine model of heart failure: lessons from a clinical case. 187
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 187
Eligibility for vericiguat in a real‐world, contemporary heart failure population 186
Mapping dependencies of BOLD signal change to end-tidal CO2: Linear and nonlinear modeling, and effect of physiological noise correction 186
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 184
Exploratory analysis of nonlinear coupling between EEG global field power and end-tidal carbon dioxide in free breathing and breath-hold tasks 184
Breathless heart: only when the neck is deep in water? 183
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 182
On the Use of Linear-Modelling-based Algorithms for Physiological Noise Correction in fMRI Studies of the Central Breathing Control 181
When the heart is burning: Amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease 180
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 179
Upright Cheyne-Stokes Respiration in Patients With Heart Failure 179
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 179
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 179
The Importance of Visceral Feedbacks: Focus on Chemoreceptors 178
Central apnoeas and ticagrelor-related dyspnoea in patients with acute coronary syndrome 178
Baroreflex sensitivity, assessed by a novel noninvasive method, holds prognostic value in systolic heart failure 177
Analysis of generic coupling between EEG activity and PETCO2 in free breathing and breath-hold tasks using Maximal Information Coefficient (MIC) 176
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 176
Role of Imaging in Cardiomyopathies 175
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 175
Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction 175
Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure 175
Totale 23.564
Salva come PNG Salva come JPEG
Categoria #
all - tutte 201.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 201.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.127 0 0 0 0 0 542 330 217 177 207 198 456
2021/20222.330 146 385 113 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/20241.162 107 34 280 90 37 88 80 49 30 39 39 289
2024/202510.696 65 80 466 207 596 585 1.383 2.351 871 949 1.993 1.150
2025/202615.363 1.363 4.006 2.931 3.638 2.944 481 0 0 0 0 0 0
Totale 38.141